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Introduction
Ischaemia-reperfusion injury (IRI) is a major cause of acute kidney injury (AKI) in both allograft and native kidneys due to the acute reduction of blood flow that produces hypoxia-induced vascular and tubular dysfunction [1, 2] . To date, there is no effective treatment to improve survival, limit injury or speed recovery except dialysis [3] . IRI and acute rejection (AR) are two major factors affecting early functional recovery of kidney allograft [4] . In the past, AR has always been the focus of the research, but with the development of clinical research and animal experiments, the impact of IRI on kidney allograft began to cause attention. Some studies showed that IRI not only cause delayed graft function (DGF), but also promote AR through the immune mechanism [5] . In addition, IRI, as a major nonantigen-dependent factor, could lead directly to chronic rejection. Therefore, IRI affects early functional recovery of kidney allograft as well as significantly decreasing the longterm survival rate of kidney allograft. How to reduce the impact of IRI on kidney allograft function is a major problem in kidney transplantation.
Animal models have demonstrated that a robust inflammatory reaction that results in tissue injury occurs following ischaemia-reperfusion (I/R) and the innate immunity plays a major role in the immune response to IRI [6] [7] [8] [9] [10] . Innate immunity is the first-line response defence against invading microorganisms by detecting pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) [11] . DAMPs are molecules released by stressed cells that act as endogenous danger signals to promote and exacerbate the inflammatory response, which activate Toll-like receptors (TLRs), purinergic receptors or the Nod-like receptor (NLR)-P3 inflammasome [12] [13] [14] . TLR-mediated cell activation induces nuclear factor kappa B (NF-jB)-dependent inflammatory cytokines and chemokines in all cells [15] . In NLR-P3 inflammasome, the activation of caspase-1 and caspase-11 confer proteolytic cleavage of pro-interleukin (IL)-1b and pro-IL-18 into the mature cytokines that trigger local inflammation inside the kidney [16] . This process induces kidney inflammation and immunopathology. Macrophages are key regulators of inflammation and fibrosis [17, 18] . After reperfusion, monocytes infiltrate the injured kidney at 24 h, differentiate into macrophages and increase in number to day 7. Macrophages secrete factors to augment, modulate or suppress inflammation. Initially, macrophages promote removal of infected or apoptotic cells at a proinflammatory state (classically activated M1 macrophages) and then contribute to the process of repair at a wound-healing state (alternative-activated M2 macrophages). However, the mechanisms that regulate macrophage activation and effector functions during the course of acute ischaemic kidney injury and repair are not well understood.
The T cell immunoglobulin domain and mucin domaincontaining molecule-3 (Tim-3), as one member of the Tim family, is identified initially as expressed on activated T helper type 1 (Th1) cells [19] . Although present researches concerning Tim-3 focus upon its role in negatively regulating Th1 cells and inducing immunological tolerance, Tim-3 has been found to be expressed on, and to have more functions in, other types of cells, including dendritic cells (DC) and monocytes/macrophages [20, 21] . Evidence gathered to date suggests that Tim-3 plays an important role in innate and adaptive immune responses. Tim-3 has either a negative or positive regulatory function on diverse cells during the immune response, and its dysregulated expression is related closely to many autoimmune diseases, viral infections and cancer [22] [23] [24] [25] . For example, the downregulation of Tim-3 expression on CD4
1 effector cells could enhance T cell activation in patients with autoimmune hepatitis [26] . However, the function of Tim-3 in kidney IRI and the molecular mechanisms that the protein regulates are not yet clear.
In the present study, we assessed the contribution of Tim-3 in kidney IRI and investigated the potential mechanisms which provide evidence that Tim-3 signalling is critical for kidney IRI, and may provide new means to ameliorate tissue immune responses in clinics.
Materials and methods

Animals and kidney IRI model
Male C57BL/6N mice (aged 6-8 weeks) were purchased from SLAC Laboratory Animal (Shanghai, China). Mice were housed under specific pathogen-free conditions receiving food and water at the Animal Center of General Hospital of Ji'nan Military Command and were adapted to laboratory conditions (temperature: 20 6 28C, relative humidity 50% and light/dark cycle: 12 h) for 1 week before experiment. The animal experiments were approved by the General Hospital of Ji'nan Military Command Animal Care and Use Committee.
Mice were food-deprived for 12 h before the procedures and were anaesthetized with intraperitoneal injection of 1% sodium pentobarbital solution (40 mg/kg). Using a midline abdominal incision, bilateral renal IRI was induced by clamping both renal pedicles for 15 min. After removal of the clamp, the kidneys were inspected for confirming reperfusion. Body temperature was maintained at 378C throughout the procedure. As a control, sham-operated mice underwent the same procedure, except clamping of the renal pedicles. To investigate the role of Tim-3, mice were injected intraperitoneally with 200 lg anti-Tim-3 antibody [RMT3-23; rat immunoglobulin (Ig)G2a, j] 1 day prior to ischaemia insult, and then killed at 6, 24 and 48 h after reperfusion. Controls were treated with rat IgG antibody or phosphate-buffered saline (PBS). At the time of death, blood was collected by retro-orbital venous plexus puncture with heparinized capillary tubes, and kidneys were harvested for further analysis.
Renal function
Renal function was assessed by measurements of serum creatinine and cystatin C. Serum for creatinine and cystatin C measurement was taken at 6, 24 and 48 h after reperfusion.
Immunohistochemistry
Kidney tissue was fixed in 10% formalin for 12 h and then embedded in paraffin wax. For assessment of injury, 5-lm sections were stained with periodic acid-Schiff (PAS). Tubular injury was assessed in PAS-stained sections using a semiquantitative scale [2] . The percentage of cortical tubules showing epithelial necrosis was assigned a score: 0 5 normal; 1 < 10%; 2 5 10-25%; 3 5 26-75%; and 4 > 5%. Sections were scored independently by two investigators who were blinded to the treatment of the animal. Ten fields of 340 magnification were examined and averaged.
Terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labelling (TUNEL) assay Apoptosis in kidney paraffin sections was detected by the TUNEL method using a commercial kit (Keygen Biotech, Nanjing, China). Negative control was prepared by omission on TdT. Positive controls were generated by treatment with DNase. TUNEL-positive cell nuclei were counted in 20 randomly selected fields of each section by two investigators who were blinded to the treatment of the animal.
Data were normalized to the mean value of the control group for statistical analysis.
Quantitative reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA (2 lg) was reverse-transcribed in a reaction volume of 20 ll using a RevertAid First Strand cDNA Synthesis Kit and Oligo dT. The product was diluted to a volume of 200 ll, and 1-ll aliquots were used as templates for amplification using the SYBR Green PCR amplification reagent (Qiagen, Valencia, CA, USA) and gene-specific primers. The primer sets used were: mouse tumour necrosis factor (TNF)-a (forward: CCTGTAGCCCACGTCGTAG; reverse: GGGAGTAGACAAGGTACAACCC), interferon (IFN)-g (forward: ACAGCAAGGCGAAAAAGGATG; reverse: TGGTGGACCACTCGGATGA), IL-6 (forward: CAATGG-CAATTCTGATTGTATG; reverse: AGGACTCTGGCTTTGT CTTTC), IL-18 (forward: TGTTGAGCATGAAAAGCCTCT AT; reverse: AGGTCTCCCGAATTGGAAAGG), chemokine (C-X-C motif) ligand (CXCL)-1 (forward: ACTGCACC-CAAACCGAAGTC; reverse: TGGGGACACCTTTTAGCAT CTT) and CXCL-2 (forward: CCAACCACCAGGCTACAGG; reverse: GCGTCACACTCAAGCTCTG). The amount of DNA was normalized to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) signal amplified in a separate reaction (forward: TATGTCGTGGAGTCTACTGGT; reverse: GAGTTGTCATATTTCTCGTGG).
Flow cytometry
Peripheral blood samples were obtained from mice and were collected into heparinized tubes. Peripheral blood mononuclear cells (PBMCs) were separated by FicollHyPaque, density gradient centrifugation (400 g for 20 min at 248C) for the following experiment. Cells were fixed and incubated with the appropriated fluorochrome-conjugated antibody for 15 min at room temperature for cell surface staining. Phycoerythrin (PE)-conjugated anti-mouse Tim-3 (clone: RMT3-23) was used, which was purchased from eBioscience (San Diego, CA, USA). Flow cytometry (FCM) analysis was performed on a Beckman Coulter FC500-MPL flow cytometer (Beckman Coulter, Brea, CA, USA). Data were analysed with FlowJo version 6.1 software (TreeStar, Ashland, OR, USA).
Immunofluorescence
Fresh tissue was snap-frozen in liquid nitrogen. Cryosections of approximately 5 lm were cut and mounted on gelatin-coated slides. Immunofluorescence was performed on cryosections using the following primary antibodies: anti-mouse Tim-3 (bs-8766R; Bioss, Woburn, MA, USA), fluorescein isothiocyanate (FITC)-conjugated anti-mouse F4/80 (sc-52664 FITC; Santa Cruz Technology, Dallas, TX, USA), anti-CD11c antibody (ab11029; Abcam, Cambridge, MA, USA) and anti-CD3 antibody (ab56313; Abcam).
Sections were blocked with 10% normal goat serum for 1 h to block non-specific binding to immunoglobulin. Then sections were incubated with primary antibody as appropriate overnight at 48C. For Tim-3, CD11c and CD3, sections were incubated further with FITC/tetramethylrhodamine isothiocyanate (TRITC)-conjugated secondary antibodies for 1 h to visualize the bound primary antibodies. Specimens were analysed using confocal microscope Leica TCS SP5 with the digital image-processing program ImageJ. Quantitative analysis of cell infiltration was performed by counting the number of positively labelled cells in 15 non-overlapping high-power fields (HPFs).
Western blot analysis
Western blot analysis was performed to measure protein expression. Kidney tissue or cells were homogenized in cold buffer and centrifuged at 14000 g for 20 min. The protein extracts were subjected to electrophoresis on 12% or 15% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) gel that depends upon the molecular size of the protein and transferred to polyvinylidene difluoride (PVDF) membrane. The membranes were incubated in 5% non-fat milk for 1 h at room temperature and then incubated with the following primary antibodies: cleaved anti-caspase-3 antibody (ab13847; Abcam), antiprocaspase-3 antibody (ab32150; Abcam), anti-GAPDH antibody (KGAA002; Keygen Biotech), TLR-4 (KG22755; Keygen Biotech), NF-jB p105/p50 (pSer 337) (KG11017; Keygen Biotech), anti-CARD12 (NLR-C4) antibody (PB0658; Boster Biological Technology, Pleasanton, CA, USA), anti-IKB alpha (phospho S36) antibody (ab133462; Abcam), anti-caspase-1 antibody (ab108362; Abcam) and anti-pro caspase1 1p10 1p12 antibody (ab179515; Abcam), followed by incubation with horseradish peroxidase-conjugated secondary antibody. Proteins were detected using enhanced chemiluminescence detection reagents. Protein loading was normalized to GAPDH expression using anti-mouse GAPDH antibody.
Cell culture and hypoxia/reoxygenation treatment
Mouse macrophages (Raw 264.7 cells; ATCC, Manassas, VA, USA) were cultured in RPMI-1640 medium containing 10% fetal bovine serum (FBS) at 378C with 5% CO 2 . After stable transfection, Raw 264.7 cells were incubated at 48C for 16 h in Soltran preserving solution in a closed chamber containing 8% O 2 and 5% CO 2 balanced with N 2 , and then recovered for 12 h at 378C in RPMI-1640 medium in a normal cell incubator. After hypoxia/reoxygenation, Raw 264.7 cell medium was collected for the following experiment.
shRNA transfection GenePharma Co (Shanghai, China): Tim-3-mus-157 (5'-GGT TGG TAA GAA TGC CTA TCT-3'), Tim-3-mus-183 (5'-GCA GTT ACA CTC TAT CTA CAC-3'), Tim-3-mus-499 (5'-GGA CTC TAC TAC AGC TTC TCC-3') and Tim-3-mus-608 (5'-GCTGAT GAA ATT AAG GAC TCT-3'). A negative control shRNA duplex (shRNA-NC 5'-TTC TCC GAA CGT GTC ACG T-3') was used, which did not target any known murine gene and was synthesized by Shanghai GenePharma Co (Shanghai, China). shRNA transfection was carried out with lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the procedure recommended by the manufacturer.
Enzyme-linked immunosorbent assay (ELISA)
Frozen kidneys were homogenized in PBS containing 1% Triton X-100, 1 mM ethylenediamine tetraacetic acid (EDTA) and 1% protease inhibitor cocktail. The cellcultured supernatants were collected and centrifuged. Kidney homogenate TNF-a, IFN-g, IL-6, IL-18, CXCL-1 and CXCL-2 content and their concentration in cultured supernatants were determined by commercially available ELISA kit (Keygen Biotech). ELISA was performed according to the manufacturer's instructions.
Human blood sample collection and isolation of peripheral blood mononuclear cells
This study was approved by the ethics committee of General Hospital of Ji'nan Military Command, Ji'nan, China. Written informed consent was obtained from patients for the collection and study of blood samples. Patients were included when the following inclusion criteria were met: (1) adult patients (age 18 $ 60 years); (2) acute kidney injury after ischaemia-reperfusion injury, a rapid decrease in the function of kidney, which was diagnosed if any one of the following was present: increase in serum creatinine (Scr) ! 0Á3 mg/dl (! 26Á4 lmol/l) within 48 h; increase in Scr to ! 1Á5 times baseline measured within the previous 7 days; or urine volume < 0Á5 ml/kg/h for 6 h. Exclusion criteria were as follows: kidney dysfunction caused by primary glomerular and tubular kidney disease or secondary kidney disease induced by diabetes or hypertension.
Peripheral blood samples were obtained from patients and volunteer donors and were collected into heparinized tubes. PBMCs were separated by Ficoll-HyPaque, density gradient centrifugation (400 g for 20 min at 248C) for the following experiment.
Analysis of gene expression with RT-PCR array
Total RNA was isolated from PBMCs of patients and volunteer donors using TRIzol V R reagent (Invitrogen, Carlsbad, CA, USA; #15596-026). RNAs from six patients were pooled and used for cDNA probe preparation using RevertAid First Strand cDNA Systhesis Kit (Thermo Fisher, Fremont, CA, USA; #K1622). The human inflammasomes RT 2 Profiler TM PCR Arrays (Qiagen; #PAHS-097Z) were used to analyse the inflammation-related gene expression using real-time RT-PCR according to the manufacturer's instruction.
Statistical analysis
Data were expressed as mean 6 standard deviation (s.d.). Multiple group comparisons were performed by one-way analysis of variance (ANOVA), followed by the Bonferroni procedure for comparison of means. Comparisons between two groups were analysed by the two-tailed t-test. Differences were considered to be significant at P < 0Á05. Analysis of the data was performed using GraphPad PRISM software (GraphPad Software, La Jolla, CA, USA).
Results
Expression of Tim-3 is enhanced on monocytes/ macrophages after kidney IRI
To determine whether Tim-3 participate in kidney IRI, we investigated the expression of Tim-3 in PBMCs from control mice that were subjected to kidney IRI using flow cytometric analysis. Compared with that of sham mice, Tim-3 expression from peripheral blood was upregulated significantly at 6, 24 and 48 h in control mice, suggesting that Tim-3 expression is induced following kidney IRI (Fig. 1a,b) . As is well known, macrophages are key regulators of inflammation and fibrosis. To investigate whether the expression of Tim-3 is induced on monocytes/macrophages after kidney IRI, we detected the expression of Tim-3 on monocytes/macrophages from control mice using immunofluorescence. Kidney tissue from sham and control mice were stained with antibody to F4/80 1 , characterizing macrophages, in combination with anti-Tim-3. We found that the expression of Tim-3 was up-regulated on F4/80 1 macrophages in kidney tissue from control mice compared with that obtained from sham mice (Fig. 1c) . Meanwhile, no difference was detected in Tim expression and the number of CD3 1 T cells and CD11c 1 dendritic cells (Supporting information, Fig. S1 ). Taken together, these results suggested that Tim-3 expression is induced on monocytes/ macrophages after kidney IRI.
Anti-Tim-3 antibody treatment protects against reperfusion injury and prevents renal dysfunction
To confirm further the role of Tim-3 in kidney IRI, we assessed kidney function by measuring serum creatinine and cystatin C and investigating histological features. In comparison with sham mice, control mice caused significant renal dysfunction at 6, 24 and 48 h after reperfusion, as suggested by a significant increase in serum creatinine and cystatin C (Fig. 2a,b) . However, the mice that were administered with anti-Tim-3 antibody RMT3-23 1 day before ischaemia had a marked reduction in serum creatinine and cystatin C. Histology indicated that the kidney tissue from control group had tubular damage in the outer medulla, evidenced by widespread tubular necrosis, loss of the brush border, cast formation, tubular dilation and significant infiltration of neutrophils. In contrast, kidney tissues obtained from mice treated with RMT3-23 showed significantly less tubular damage at the same time-point (Fig. 2c) . Quantification of the tubular damage showed a markedly lower mean tubular injury score from the kidney of mice treated with anti-Tim-3 antibody (Fig. 2d) . These results indicated that Anti-Tim-3 antibody could protect against reperfusion injury and prevent renal dysfunction, suggesting that Tim-3 exacerbates kidney IRI. The of infiltrating macrophages significantly compared with control mice at the same time-point (Fig. 3a,b) .
To assess the role of macrophage activation products locally at the site of injury, we analysed the expression of the cytokines IFN-g, IL-6, CXCL1, IL-18, CXCL2 and TNF-a by ELISA in ischaemic kidneys. Kidneys from control mice showed a marked up-regulation of TNF-a, IL-18, CXCL1 and CXCL2 at 6, 24 and 48 h, whereas IFN-g and IL-6 were up-regulated only at 24 and 48 h after kidney IRI compared with sham mice (Fig. 4) . Consistent with the diminished macrophage infiltration in RMT3-23-treated mice, the results showed a reduced expression of the Fig. 4 . Diminished macrophage infiltration is associated with decreased cytokine production. At 6, 24 and 48 h after reperfusion, tumour necrosis factor (TNF)-a, interferon (IFN)-g, interleukin (IL)-6, IL-18, chemokine (C-X-C motif) ligand (CXCL)-1 and CXCL-2 levels were assessed by enzyme-linked immunosorbent assay (ELISA). *P < 0Á05 versus sham; # P < 0Á05 versus control. All the results are from three independent experiments. Graph represents the mean 6 standard deviation (error bars).
cytokines produced by macrophages, confirming at a molecular level the observed differences in organ function mentioned above.
Anti-Tim-3 antibody treatment reduces apoptosis in ischaemic kidneys
Kidney IRI is associated with ischaemia-induced apoptosis, which might contribute to kidney dysfunction. To evaluate the role of Tim-3 in the development of apoptosis in ischaemic kidneys, we scored the rate of apoptotic bodies in kidney tissues by TUNEL assay, the expression of anti-apoptotic Bcl-2, proapoptotic Bax and cleaved caspase-3 by Western blotting. In control mice, approximately 20% of TUNEL-positive cells were noted in the ischaemic kidney, whereas only a few TUNELpositive cells were seen in non-ischaemic kidneys of (Fig. 5a,b) . The expression of Bax was increased significantly and the expression of Bcl-2 was decreased markedly after reperfusion. Consistently, the cleaved caspase-3 intensity increased in the control mice compared with the sham mice, whereas RMT3-23 increased significantly the expression of Bcl-2, decreased Bax and inhibited kidney IRI-induced caspase-3 activation (Fig. 5c,d ). Gal-9/Tim-3 signalling regulates cytokine and chemokine secretion in macrophages
We analysed further the immunomodulatory function of Tim-3 in cell culture experiments, designed to mimic invivo kidney IRI settings. Tim-3 is efficiently overexpressed or knocked down in stably transfected mouse macrophages (Supporting information, Fig. S2 ). The results showed that the expression of cytokines and chemokines, including TNF-a, IL-6, CXCL1, IL-18 and CXCL2, was increased significantly by over-expression of Tim-3, either at gene or protein levels, in macrophages following hypoxia/reoxygenation (Fig. 6a,b) . Conversely, knock-down of Tim-3 led to down-regulation of these cytokines and chemokines. It has been demonstrated that the intracellular signalling of Tim-3 begins after binding to its ligand, galectin 9 (Gal-9) [27] . To confirm further the involvement of Gal-9/Tim-3 signalling in regulating cytokine and chemokine secretion in macrophages, we detected the secretion of TNF-a and IL-6 from macrophages after over-expression of Tim-3 and addition of anti-Gal-9 antibody. As shown in Fig. 7 , the expression of TNF-a and IL-6 increased by over-expression of Tim-3. Addition of anti-Gal-9 antibody could suppress the increase of TNF-a and IL-6 expression by overexpression of Tim-3. These results demonstrated that the role of Gal-9/Tim-3 signalling in IRI induced macrophage activation leading to the secretion of proinflammatory cytokines and chemokines, which may cause further renal cell necrosis.
Tim-3 is involved in regulating TLR-4/NF-jB signalling during kidney IRI
Previous studies have shown that TLR-4 plays an important role in the pathogenesis of kidney IRI, which is central in the innate immune response that leads to kidney injury [28, 29] . To determine if Tim-3 was involved in regulating TLR-4/NF-jB signalling during kidney IRI, we detected TLR-4 expression using Western blotting and quantitative PCR (qPCR). We found that TLR-4 expression was increased significantly in the kidney tissue of control mice when compared with sham group mice, while RMT3-23 reduced the expression of TLR-4 markedly (Fig. 8a-c) . To confirm the role of Tim-3 in TLR-4/ NF-jB signalling, we investigated it in stably transfected mouse macrophages using culture cell experiments. Similar to the results mentioned above, over-expression of Tim-3 increased TLR-4 expression, while knock-down of Tim-3 decreased its expression (Fig. 8d,e) . The expression of TLR-4 decreased when Tim-3-expressing macrophages were pretreated with anti-Gal-9 (Fig. 8f,g ). NF-jB is the downstream effector of the TLR-4 signalling pathway, so we investigated the NF-jB activation using Western blotting. The results showed that kidney IRI induced the activation of NF-jB, and pretreatment with TAK-242, a selective TLR-4 signal transduction inhibitor, suppressed the activation of NF-jB. Over-expression of Tim-3 could partly reverse the suppressive effect of TAK-242 on the activation of NF-jB (Fig. 8h) . Moreover, we detected the secretion of TNF-a and IL-6 from macrophages. TAK-242 could suppress the secretion of TNF-a and IL-6 from macrophages induced by IRI, while overexpression of Tim-3 could partly increase their secretion (Fig. 8i) . Taken together, these results demonstrated Tim-3 is involved in regulating TLR-4/NF-jB signalling during kidney IRI.
Tim-3 is involved in regulating NLR-C4 inflammasome activation during kidney IRI
Inflammasomes are central players in a series of infectious diseases and inflammatory processes. To investigate the role of Tim-3 in inflammasome activation, we tested caspase-1 cleavage and IL-1b and IL-18 secretion in kidney tissue using immunoblotting and ELISA. The results showed that caspase-1 cleavage and IL-1b and IL-18 secretion were increased significantly in the kidney tissue of Fig. 7 . Galectin 9 (Gal-9)/T cell immunoglobulin domain and mucin domain-containing molecule-3 (Tim-3) signalling regulates tumour necrosis factor (TNF)-a and interleukin (IL)-6 secretion in macrophages. TNF-a and IL-6 in Tim-3-expressing macrophages were detected using enzyme-linked immunosorbent assay (ELISA) with or without addition of anti-Gal-9 antibody. Addition of antiGal-9 antibody could suppress TNF-a (a) and IL-6 (b) secretion induced by over-expression of Tim-3. TNF-a: **P < 0Á01 versus ischaemia-reperfusion (I/R), ## P < 0Á01 versus I/R1Tim-3; IL-6: **P < 0Á01 versus control, ## P < 0Á01 versus I/R, && P < 0Á01 versus I/R1Tim-3. All the results are from three independent experiments. Graph represents the mean 6 standard deviation (error bars). show a dramatic elevation of TLR-4 expression levels at 6, 24 and 48 h after reperfusion over shamoperated mice (grey bars), whereas TLR-4 expression in RMT3-23-treated mice (dot bars) were significantly lower at the same time-point. Mean 6 standard deviation (s.d.) (error bars) of three separate experiments performed in triplicate. *P < 0Á05 control mice versus RMT3-23-treated mice. (d,e) TLR-4 expression was measured by Western blot in whole lysates from macrophages expressing or knock-downing Tim-3. Mean 6 s.d. (error bars) of three separate experiments performed in triplicate. *P < 0Á05 versus ischaemia-reperfusion (I/R)1vector. (f,g) TLR-4 expression in Tim-3-expressing macrophages were detected using Western blot with or without addition of anti-galectin 9 (Gal-9) antibody. Addition of anti-Gal-9 antibody could suppress TLR-4 expression induced by over-expression of Tim-3. *P < 0Á05 I/R versus I/R1Tim-3, I/ R1Tim-3 versus I/R1Tim-31anti-Gal-9. All the results are from three independent experiments. Graph represents the mean 6 s.d. (error bars). (h, i) Over-expression of Tim-3 partly reverses the suppressive effect of TLR-4 signal transduction inhibitor TAK242 on NF-jB activation and tumour necrosis factor (TNF)-a and IL-6 secretion. *P < 0Á05 I/R versus I/R1TAK242, I/R1vector1TAK242 versus I/R1Tim-31TAK242. All the results are from three independent experiments. Graph represents the mean 6 standard deviation (error bars). control mice when compared with sham group mice, while RMT3-23 reduced them markedly (Fig. 9a,b) . Consistent with the result from mice, over-expression of Tim-3 in macrophages promotes caspase-1 cleavage and IL-1b, IL-18 secretion, while knock-down of Tim-3 in macrophages reduces them (Fig. 9c,d ). These results suggested that Tim-3 is involved in inflammasome activation. In our previous result, to investigate changes in inflammasome-related gene expression in AKI, we examined the differences in inflammasome-related gene expression between healthy individuals and AKI patients using the human inflammasome RT Profiler PCR Arrays (Supporting information, Fig. S3 ). Of the 84 probed genes, 44 genes in AKI patients were expressed differentially more than twofold compared with the expression observed in healthy individuals (data not shown). Among the identified candidates, NLR-C4, one of the NLR family, has attracted our attention. NLR-C4 nucleates distinct inflammasome complexes that promote caspase-1 activation and secretion of the proinflammatory cytokines IL-1b and IL-18. To confirm the regulatory function of Tim-3 in NLR-C4 inflammasome activation, we investigated the expression of NLR-C4 using Western blotting and qPCR. The results showed that NLR-C4 expression was increased significantly in the kidney tissue of control mice when compared with sham group mice, while RMT3-23 reduced the expression of NLR-C4 markedly (Fig. 9e,f) . Similar results were obtained from macrophages (Fig. 9g,h ). These results suggested that Tim-3 is involved in NLR-C4 inflammasome activation during kidney IRI.
Discussion
The pathogenesis of kidney injury induced by I/R is complex and diverse. It is thought that the excessive inflammatory response induced by I/R is the main cause of kidney injury [30] . The innate immune system, known as the first line of defence, plays an important role in kidney IRI. In transgenic mice, monocytes/macrophages and their produced cytokines, IL-1b, IL-6, infiltrate kidney tissue in days 1-5 following kidney I/R [31] . Infiltrating monocytes/ macrophages secrete IL-8, macrophage inflammatory protein-2 (MIP-2) and other factors to promote their activation [32] . Activated monocytes/macrophages exert antiinflammatory effects through producing inflammatory cytokines IL-1a, IL-6, IL-12, IL-18 and TNF-a, and monocytes/macrophages may infiltrate into kidney tissue depending on chemokines [31, 33, 34] . Compared with control mice, kidney injury is reduced significantly in chemokine-deficient mice. In our study, macrophage infiltration was observed at 6 h following kidney IRI and is time-dependent, which is consistent with that reported in previous literature [35, 36] . We also found that the secretion of monocytes/macrophages produced cytokines TNFa, IL-18 and chemokines CXCL-1, CXCL-2 increase significantly, suggesting that monocytes/macrophages participate in early innate immune response during kidney IRI. The initial reason for tissue injury in kidney IRI is acute decrease in blood flow, which results in ischaemia and hypoxia-induced vascular and tubular dysfunction. Apoptosis and macrophage cytotoxicity play an important role in kidney IRI [37] . In this study, we found that there were different pathological changes of tubular epithelial cell swelling, vacuolar degeneration and necrosis in I/R mice. The kidney injury score was markedly higher than that in the sham-treated group. The apoptotic index of TUNEL assay, the apoptotic pathway related gene bax/bcl-2 expression ratio and the caspase-3 cleavage in I/R group increases compared with the sham-treated group, suggesting that early injury induces the apoptosis and necrosis of renal endothelial and epithelial cells.
Tim-3 is a co-stimulatory molecule found on the surface of activated Thl cells, which is involved in specific immune responses by negatively regulating the function of Th1 cells. Abnormalities or intervention of this negative regulatory pathway will result in or exacerbate the Th1 dominant autoimmune response, e.g. multiple sclerosis, allograft rejection and even anti-viral immune responses. With further research, Tim-3 has been found to be expressed in DC, macrophages, mast cells and other natural immune cells with different functions. Tim-3 on macrophages or natural immune cells functions as a positive regulator, which promotes the release of inflammatory mediators, e.g. TNF-a, IL-6. These studies suggest that Tim-3 signalling plays a bidirectional immunomodulatory role in different disease models and in different cell types. Recent studies have showed that Tim-3 plays a critical role in monocytes/macrophages pattern recognition and phagocytosis of apoptotic cells [38, 39] . However, the role of Tim-3 in kidney IRI and its related mechanism remain unclear. In the present study, in an established murine model of kidney IRI, antiTim-3 antibody RMT3-23 ameliorates biochemical and histological kidney injury, reduces apoptosis and decreases macrophage infiltration and cytokine production in ischaemic kidneys. Similar results were from cell culture experiments. These results suggest that Tim-3 signalling enhances injury after kidney IRI and may be a therapeutic target.
Tim-3 is expressed constitutively on cells of the innate immune system in both mice and humans. It can synergize with TLRs to promote immune responses [40] . TLRs can trigger multiple downstream effects, activate the NF-jB signalling pathway, promote the production of inflammatory cytokines and chemokines, cause granulocyte and macrophage chemotaxis and increase capillary permeability to participate in kidney IRI. Meanwhile, kidney interstitial infiltrating monocytes/macrophages release inflammasomes, activate caspase-1, release IL-1b, IL-18 and other cytokines and induce kidney local inflammatory response to regulate DAMPs-induced damage process [41] [42] [43] . In our study, we found that Tim-3 is involved in TLR-4/NF- jB signalling and NLR-C4 inflammasome-mediated kidney IRI. Therefore we speculate that, after I/R, the expression of Tim-3 is enhanced on monocytes/macrophages, which induces the activation of infiltrating macrophages. Meanwhile, early injury induces the necrosis of renal endothelial and epithelial cells, which leads to DAMPs release. These DAMPs activate TLR-4 and NLR-C4 inflammasome in macrophages. Upon activation, these cells produce inflammatory cytokines and chemokines that cause further renal cell necrosis (e.g. by TNF-induced necroptosis) (Fig. 10) . Nevertheless, how Tim-3 triggers the activation of macrophages after I/R remains unclear. This requires further investigation.
This study provides evidence that Tim-3 signalling enhances injury after kidney IRI and demonstrated that Tim-3 is involved in regulating TLR-4/NF-jB signalling and NLR-C4 inflammasome activation. These findings provide evidence that Tim-3 signalling is critical for kidney IRI and may provide new means to ameliorate kidney tissue immune responses in clinics. 
Supporting information
Additional Supporting Information may be found in the online version of this article at the publisher's website: 
